Canada orders more smallpox vaccines from Bavarian Nordic

In 2022, Bavarian Nordic will start shipping a new smallpox vaccine order to the Canadian government. This order will not have any new effect on the company's guidance this year.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

Canada's government has commissioned an order worth USD 31.2m at Danish biotech company Bavarian Nordic, according to a Monday press release from the firm.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs